Literature DB >> 14529846

Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.

S Beckebaum1, V R Cicinnati, M Karliova, O Dirsch, Y Erim, A Frilling, M Malago, C E Broelsch, U Treichel, G Gerken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14529846     DOI： 10.1016/s0041-1345(03)00681-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.

Authors:  Mariarosa Tamè; Federica Buonfiglioli; Massimo Del Gaudio; Andrea Lisotti; Paolo Cecinato; Antonio Colecchia; Francesco Azzaroli; Antonietta D'Errico; Rosario Arena; Claudio Calvanese; Chiara Quarneti; Giorgio Ballardini; Antonio Daniele Pinna; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 2.  Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Brian R Davidson; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2013-12-02

Review 3.  Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Elias Xirouchakis; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.